Our Scientific Advisory Board plays a pivotal role in shaping vaccine strategies and solutions. This group also provides invaluable insights that inform Intravacc's research strategy, optimizing therapy effectiveness and value. Chaired by our Chief Scientific Officer, Virgil Schijns, the Scientific Advisory Board consists of leading experts in vaccinology, infectious diseases, and oncology.
Dr. Harry Flore is Chairman of the Supervisory Board of HAL Allergy Holding of Leiden, The Netherlands – one of Europe’s top players in the field of allergen immunotherapy and a world leader in the production of modified allergen extracts for both therapeutic and diagnostic purposes. He is also active in HALIX, a CDMO specializing in cell culture-based pharmaceutical production.
Prof. Dr. Anke Huckriede is Professor of Vaccinology at the University of Groningen, The Netherlands, and is affiliated with the University Medical Center Groningen. Huckriede’s research activities are aimed at vaccine development, with a focus on rational vaccine design. Her work on (influenza) vaccines focuses, among other things, on developing in vitro techniques for vaccine evaluation and understanding the effects of pre-existing immunity on responses to vaccination.
Dr. Paul Oostvogel is a medical microbiologist. He has been involved in the Polio Eradication Initiative from the start in 1989. He retired in 2019 as Head of the Public Health Laboratory of the Public Health Service (GGD) Amsterdam.
Dr. Paul Wichgers Schreur is a senior scientist in the field of arbovirology at Wageningen Bioveterinary Research (WBVR). Using techniques like reverse-genetics, single-molecule microscopy, and bacterial superglue, he studies the infection cycle of bunyaviruses and uses this knowledge to (co)develop therapeutic antibodies and vaccines.
Prof. Evelien Smits is Research Professor in Tumor Immunology and Cancer Immunotherapy at the University of Antwerp, Belgium. She is researching how the immune system of cancer patients can be provided with the necessary weapons to win the battle against cancer cells.